Skip to navigation Skip to content
  • The Cancer Letter on Facebook
  • The Cancer Letter on Twitter
  • The Cancer Letter on LinkedIn

The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
  • SUBSCRIBE
  • Login
  • SUBSCRIBE
  • Login
The Cancer Letter
Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
The Cancer Letter's weekly podcast of interviews, discussions, and more to dig deep into the issues that shape oncology.
New episodes every Wednesday.
SUBSCRIBE ON
Spotify Apple Podcast YouTube
Spotify Apple Podcast YouTube
on air
The Directors: Candace Johnson and Jonathan Friedberg on living through uncertainty at NCI, payment woes
PodcastThe Directors

The Directors: Candace Johnson and Jonathan Friedberg on living through uncertainty at NCI, payment woes
Directors of two neighboring cancer centers in Upstate New York will face challenges, but “we’ll get through it”

June 13, 2025
Vol.51 No.23
By Paul Goldberg
In The Headlines: Increasing incidence of early-onset cancer is “a paradigm shift oncology isn’t quite prepared for”
Podcast

In The Headlines: Increasing incidence of early-onset cancer is “a paradigm shift oncology isn’t quite prepared for”

June 11, 2025
Vol.51 No.22
In The Headlines: Kimryn Rathmell, ASCO, and “an important time in cancer research”
Podcast

In The Headlines: Kimryn Rathmell, ASCO, and “an important time in cancer research”

June 04, 2025
Vol.51 No.21
In The Headlines: Back to “business as usual” at FDA?
Podcast

In The Headlines: Back to “business as usual” at FDA?

May 28, 2025
Vol.51 No.20
In The Headlines: Wafik El-Deiry on how “America First” means investing in NCI
Podcast

In The Headlines: Wafik El-Deiry on how “America First” means investing in NCI

May 21, 2025
Vol.51 No.19
The Directors: Tom Lynch and Skip Burris on how NIH funding cuts imperil biopharma innovation—and cost patient lives
PodcastThe Directors

The Directors: Tom Lynch and Skip Burris on how NIH funding cuts imperil biopharma innovation—and cost patient lives
In a time of uncertainty, “react to the knowns, not the fear”

May 16, 2025
Vol.51 No.19
By Katie Goldberg
In the Headlines: “There’s no one to stand up for NCI right now.”
Podcast

In the Headlines: “There’s no one to stand up for NCI right now.”

May 14, 2025
Vol.51 No.18
In the Headlines: Centering patients as cancer research infrastructure is dismantled
Podcast

In the Headlines: Centering patients as cancer research infrastructure is dismantled

May 07, 2025
Vol.51 No.17
In The Headlines: Are cancer registries on the chopping block, and what does it mean if they are?
Podcast

In The Headlines: Are cancer registries on the chopping block, and what does it mean if they are?

April 30, 2025
Vol.51 No.16
In the Headlines: What’s in Trump’s draft budget?
Podcast

In the Headlines: What’s in Trump’s draft budget?

April 23, 2025
Vol.51 No.15

Posts navigation

Previous1…56789Next

Trending Stories

  • FDA’s second rejection of Replimune’s melanoma treatment stirs worry among oncologists, patients
    “Patients are owed another review.”
  • Vinay Prasad’s CV inaccurately claims past membership on the President’s Cancer Panel
  • CDC’s recommendation to delay infant hepatitis B shot is likely to raise infections, JAMA studies show
  • Breakthrough Therapy designation, ASCO plenary, and NEJM publication notwithstanding, breast cancer drug camizestrant gets a No from ODAC
  • CBER Director Vinay Prasad dared to “say no to drugs”
  • Reforms pending at USPSTF, plus, FDA rejects promising melanoma drug for the second time

ABOUT
ABOUT
About The Cancer Letter
Accessibility Statement
Our Contributors
Editorial policies
Store
SUBSCRIPTIONS
SUBSCRIPTIONS
Our readers
Pricing
News alerts
About IP login
Job board
CONTACT
CONTACT
Contact us
Submission guidelines
Advertise
Careers
SEE ALSO
Cancer History Project
The Cancer Letter
Copyright © 2026 The Cancer Letter Inc. All rights reserved.
Privacy Policy
Terms & Conditions
FOLLOW US
Instagram
Twitter
LinkedIn
Facebook
Vimeo
Scroll to top
Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.
SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.
LOGINSUBSCRIBE NOW
SEARCH DATE
SEARCH TEXT
      Cancel
      OK
      Cancel
      OK
      Delete Account
      Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below
      No

      Never miss an issue!

      Get alerts for our award-winning coverage in your inbox.

      Login

       
      Forgot Password?

      Site license subscribers:
      Log in with your IP | Register a sponsored account